BBNX Beta Bionics Inc: Operating Margin

Corporate emblem and logo of iLet Bionic Pancreas (BBNX)

The resilience of Beta Bionics Inc (BBNX) is based on the hype surrounding the autonomous iLet and the expansion of insurance coverage. The operating margin confirms this growth, where the value -72.80 reflects the current margin level. High markups on patented devices ensure scalability, while the rapid integration of the artificial pancreas into medical practice solidifies the company's dominance in its niche.

BBNX: Beta Bionics Operating Margin 01/31/2025 - 11/20/2026

Beta Bionics Inc - analytical breakdowns and key metrics (BBNX)

- share price and consensus valuation forecast:
Fundamental company analysis:BBNX, Beta Bionics, Inc.
Brand item of iLet Bionic Pancreas

For Beta Bionics Inc (BBNX), the operating margin reflects the efficiency of the commercial rollout of the bionic pancreas, excluding debt obligations. This metric is calculated as the ratio of operating income to revenue, measuring the portion of funds remaining after covering all production costs. The operating margin trend demonstrates the company's ability to scale through physician partnerships. Growth in this indicator confirms the success of its strategy for sole market dominance. Consistently high margins signal a sustainable technological advantage.

Competitors of Beta Bionics Inc (BBNX)

BSX (Boston Scientific Corporation Inc.) - Operating Margin|Operating Margin Edwards Lifesciences Inc.|Operating Margin RMD|Operating Sales Margin Insulet Corporation PODD|Operating Profitability Zimmer Biomet ZBH|CooperVision - Operating Profitability|ALGN - Operating Profitability|GMED: Operating Profitability|TMDX (TransMedics Corp) - Operating Sales Margin|Alphatec Holdings, Inc. - Operating Profit Rate|AORT (Artivion Corp) - Operating Margin|Operating Return on Sales Enovis Corp ENOV|Operating Profitability Integra LifeSciences Corp (IART)|Establishment Labs (ESTA) - Operating Profitability Margin|IRADIMED Inc. - Operating Sales Margin|Operating Margin Embecta Corp. EMBC|Tandem Diabetes Care Inc - Operating Margin|Profitability of Operations AxoGen Inc AXGN|SI-BONE (SIBN) - Operating Profitability|Operating Profit Margin OFIX (Orthofix Corp)|BVS (Bioventus Inc) - Operating Margin|Operating Sales Margin OrthoPediatrics Corp. (KIDS)|Operating Margin TMCI|SRTA - Operating Return on Sales|Operating Profitability Carlsmed Inc CARL|RXST: Return on Sales by Operating Profit|CLPT: Operating Sales Margin|stereotaxis.com - Operating Profit Ratio|NeuroStar (STIM) - Operating Profitability|SGHT - Profitability of Operations|Operating Profitability Orchestra BioMed|Return on Sales by Operating Profit ANIK (Anika Therapeutics)|Operating Profitability inspiremd.com (NSPR)|Jin Medical International Ltd - Return on Sales by Operating Profit|Operating Margin VANI (Vivani Medical Inc)|XTNT: Return on Sales by Operating Profit|NMTC - Operating Profitability|MODD: Operating Profitability|MYO: Operating Margin|envoymedical.com - Operating Profit Rate|Operating Sales Margin VVOS|Operating Return on Sales enVVeno NVNO|Operating Margin SINT|TNON - Operating Return on Sales|Operating Profitability ReWalk Robotics LFWD|AMIX: Return on Sales by Operating Profit|IVF - Operating Profitability|Operating Return on Sales Bone Biologics Corp|AXNX: Operating Margin|Operating Sales Margin BIOLASE, Inc.|Operating Sales Margin DYNT|Operating Sales Margin Paragon 28 (FNA)|Operating Profitability INVO Bio (INVO)